Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
2020 · Cell · 4,457 citations
https://doi.org/10.1016/j.cell.2020.06.043
E
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
145
Papers
13.6K
Citations
36
h-index
65
i10-index
Elena Giorgi is an academic researcher from Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa. The author has contributed to research in topics: HIV Research and Treatment & HIV/AIDS drug development and treatment & HIV/AIDS Research and Interventions. The author has an h-index of 36, co-authored 124 publications.
ORCID: 0000-0003-2968-1033Papers by this author
worksHIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
2019 · Cell Host & Microbe · 182 citations
https://doi.org/10.1016/j.chom.2018.12.001
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection
2018 · Nature Communications · 136 citations
https://doi.org/10.1038/s41467-018-04217-5
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
2022 · Nature Medicine · 132 citations
https://doi.org/10.1038/s41591-022-01815-1
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
2022 · Nature Medicine · 112 citations
https://doi.org/10.1038/s41591-022-01953-6
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial
2024 · Nature Medicine · 45 citations
https://doi.org/10.1038/s41591-024-03247-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat